Issue 2/2019
Content (26 Articles)
The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review
Dustin H. Marks, Jean-Phillip Okhovat, Dina Hagigeorges, Athena J. Manatis-Lornell, Steven J. Isakoff, Mario E. Lacouture, Maryanne M. Senna
The next generation personalized models to screen hidden layers of breast cancer tumorigenicity
F. Afzali, P. Akbari, H. Naderi-Manesh, M. Gardaneh
Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up
Sherry X. Yang, Eric C. Polley
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion
Landry K. Kamdem, Jingyue Xi, Brandi L. Clark, Bryana J. Gregory, Kelley M. Kidwell, Ana-Maria Storniolo, Vered Stearns, Daniel F. Hayes, Christina L. Gersch, James M. Rae, N. Lynn Henry, Daniel L. Hertz
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
Ulrik Narbe, Martin Sjöström, Carina Forsare, Pär-Ola Bendahl, Sara Alkner, L. M. Fredrik Leeb-Lundberg, Kristina Lövgren, Lisa Rydén, Christian Ingvar, Mårten Fernö
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
Mariana Ferreira Leal, Ben P. Haynes, Fiona A. MacNeill, Andrew Dodson, Mitch Dowsett
SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma
Emily A. Bossart, Nilgun Tasdemir, Matthew J. Sikora, Amir Bahreini, Kevin M. Levine, Jian Chen, Ahmed Basudan, Britta M. Jacobsen, Timothy F. Burns, Steffi Oesterreich
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
Jangsoon Lee, Bora Lim, Troy Pearson, Kuicheon Choi, Jon A. Fuson, Chandra Bartholomeusz, Linda J. Paradiso, Thomas Myers, Debu Tripathy, Naoto T. Ueno
ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer
Zhanwei Wang, Dionyssios Katsaros, Nicoletta Biglia, Yi Shen, Lenora Loo, Xiao Yu, Hongyan Lin, Yuanyuan Fu, Wen-Ming Chu, Peiwen Fei, Yan Ni, Wei Jia, Xiaobei Deng, Biyun Qian, Herbert Yu
Breast sensibility after mastectomy and implant-based breast reconstruction
E. Bijkerk, S. M. J. van Kuijk, J. Beugels, A. J. M. Cornelissen, E. M. Heuts, R. R. W. J. van der Hulst, S. M. H. Tuinder
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit
Alexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, Jean-Marc Classe, Monique Cohen, Fabien Reyal, Chafika Mazouni, Marie-Pierre Chauvet, Nicolas Chopin, Pierre-Emmanuel Colombo, Eva Jouve, Emile Darai, Roman Rouzier, Charles Coutant, Pierre Gimbergues, Anne-Sophie Azuar, Christine Tunon de Lara, Eric Lambaudie, Gilles Houvenaeghel
Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study
R. Wuerstlein, R. Kates, O. Gluz, E. M. Grischke, C. Schem, M. Thill, S. Hasmueller, A. Köhler, B. Otremba, F. Griesinger, C. Schindlbeck, A. Trojan, F. Otto, M. Knauer, R. Pusch, N. Harbeck, E.-M. Grischke, N. Harbeck, C. Schem, O. Gluz, M. Thill, S. Hasmüller, A. Köhler, B. Otremba, F. Griesinger, C. Schindlbeck, T. Reimer, J. Krauter, O. Tomé, K. Friedrichs, U.-S. Albert, G. Gebauer, S. Ackermann, I. Scheffen, G. Kaltenecker, F. Overkamp, I. Schrader, J. Potenberg, H.-M. Enzinger, A. Trojan, F. Otto, R. Pusch
Loss of HER2 after HER2-targeted treatment
Tanja Ignatov, Franceska Gorbunow, Holm Eggemann, Olaf Ortmann, Atanas Ignatov
Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma
Shearwood McClelland III, Jess Hatfield, Catherine Degnin, Yiyi Chen, Timur Mitin
Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval
Ingrid G. M. Poodt, Robert-Jan Schipper, Bianca T. A. de Greef, Guusje Vugts, Adriana J. G. Maaskant-Braat, Frits H. Jansen, Dirk N. J. Wyndaele, Adri C. Voogd, Grard A. P. Nieuwenhuijzen, R. M. H. Roumen, E. J. T. Luiten, E. J. T. Rutgers, M. T. F. D. Vrancken-Peeters, M. Bessems, J. M. Klaase, S. Muller, A. B. Francken, T. Van Dalen, L. Jansen, S. A. Koopal, Y. L. J. Vissers, M. L. Smidt, J. W. S. Merkus, C. M. E. Contant, P. H. Veldman, E. M. H. Linthorst-Niers, J. R. van der Sijp, O. R. Guicherit, L. B. Koppert, A. M. Bosch, L. J. A. Strobbe, M. S. Schlooz-Vries, I. E. Arntz, J. A. van Essen, J. W. D. de Waard, B. C. Vrouenraets, B. van Ooijen
The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients
M. L. Gregorowitsch, A. Ghedri, D. A. Young-Afat, R. Bijlsma, I. O. Baas, C. van Schaik-van de Mheen, M. J. Agterof, E. Göker, D. ten Bokkel Huinink, H. J. G. D. van den Bongard, H. M. Verkooijen
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Henry T. Lynch, Nadine Tung, Susan Armel, Leigha Senter, Christian F. Singer, Robert Fruscio, Fergus Couch, Jeffrey N. Weitzel, Beth Karlan, William D. Foulkes, Pal Moller, Andrea Eisen, Peter Ainsworth, Susan L. Neuhausen, Olufunmilayo Olopade, Ping Sun, Jacek Gronwald, Steven A. Narod
Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material
A. M. Sofie Berghuis, Carolien H. M. van Deurzen, Hendrik Koffijberg, Leon W. M. M. Terstappen, Stefan Sleijfer, Maarten J. IJzerman
A high-risk luminal A dominant breast cancer subtype with increased mobility
Liping Guo, Guoji Chen, Wen Zhang, Lulin Zhou, Ting Xiao, Xuebing Di, Yipeng Wang, Lin Feng, Kaitai Zhang
Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis
Stephanie R. Rice, Steven J. Feigenberg, Muhammad Hamza, Jason K. Molitoris, Søren M. Bentzen, Katherine H. R. Tkaczuk, Paula M. Rosenblatt, Emily C. Bellavance, Elizabeth M. Nichols
Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors
Gitana Maria Aceto, Khalid Dafaallah Awadelkarim, Marta Di Nicola, Carmelo Moscatello, Mattia Russel Pantalone, Fabio Verginelli, Nasr Eldin Elwali, Renato Mariani-Costantini
Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
Carmen van Dooijeweert, Ivette A. G. Deckers, Inge O. Baas, Elsken van der Wall, Paul J. van Diest
Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany
Daniela Doege, Melissa Suk-Yin Thong, Lena Koch-Gallenkamp, Heike Bertram, Andrea Eberle, Bernd Holleczek, Ron Pritzkuleit, Mechthild Waldeyer-Sauerland, Annika Waldmann, Sylke Ruth Zeissig, Lina Jansen, Hermann Brenner, Volker Arndt
Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients
Chara Stavraka, Athanasios Pouptsis, Leroy Okonta, Karen DeSouza, Philip Charlton, Matthaios Kapiris, Anthony Marinaki, Eleni Karapanagiotou, Dionysis Papadatos-Pastos, Janine Mansi
Validation of the breast cancer surveillance consortium model of breast cancer risk
Jeffrey A. Tice, Michael C. S. Bissell, Diana L. Miglioretti, Charlotte C. Gard, Garth H. Rauscher, Firas M. Dabbous, Karla Kerlikowske
Corneal features in trastuzumab emtansine treatment: not a rare occurrence
Els Deklerck, Hannelore Denys, Elke O. Kreps